{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:17:25Z","timestamp":1780460245956,"version":"3.54.1"},"reference-count":58,"publisher":"Informa UK Limited","issue":"10","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["Current Research Grant."],"award-info":[{"award-number":["Current Research Grant."]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2025,10,3]]},"DOI":"10.1080\/14712598.2025.2574983","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:32:31Z","timestamp":1760369551000},"page":"1071-1085","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Progress in the use of biological therapies to treat paroxysmal nocturnal hemoglobinuria: focus on patient profiling"],"prefix":"10.1080","volume":"25","author":[{"given":"Francesco","family":"Versino","sequence":"first","affiliation":[{"name":"Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico","place":["Milan, Italy"]},{"name":"University of Milan","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Fattizzo","sequence":"additional","affiliation":[{"name":"Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico","place":["Milan, Italy"]},{"name":"University of Milan","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.14128"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2016.1.208"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252212104"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.14281"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26882"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024025975"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01190-9"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-09-311381"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21608"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-04-1717"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-04052-z"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1502950"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01157"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.14026"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1269325"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2201664"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024027574"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-09-876136"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13783"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-025-06193-5"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-09-876805"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27412"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-208072"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27413"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-204659"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061648"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-094136"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-200400"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.281780"},{"key":"e_1_3_6_32_1","article-title":"Results of COBALT, a phase II clinical trial of coversin in PNH","volume":"313","author":"Hill A","year":"2018","unstructured":"Hill A, Windyga J, Robak T, et al. Results of COBALT, a phase II clinical trial of coversin in PNH. EHA Lib. 2018;PF313 [Abstract].","journal-title":"EHA Lib"},{"key":"e_1_3_6_33_1","first-page":"835","volume-title":"Efficacy and safety of pozelimab plus cemdisiran in patients with paroxysmal nocturnal haemoglobinuria who are na\u00efve to complement inhibition","author":"Griffin M","year":"2025","unstructured":"Griffin M, Jang J, Aurand L et al. Efficacy and safety of pozelimab plus cemdisiran in patients with paroxysmal nocturnal haemoglobinuria who are na\u00efve to complement inhibition. EHA Library; 2025. p. 835 [abstract]."},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022009129"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2029073"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(22)00210-1"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-024-02827-8"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2308695"},{"key":"e_1_3_6_39_1","volume-title":"The 2-year safety and efficacy of iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria (PNH) from APPLY- and APPOINT-PNH studies who entered the roll-over extension program (REP)","author":"Risitano A","year":"2025","unstructured":"Risitano A, Kulasekararaj A, Scheinberg P, et al. The 2-year safety and efficacy of iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria (PNH) from APPLY- and APPOINT-PNH studies who entered the roll-over extension program (REP). EHA Library; 2025, PF660 [abstract]."},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(25)02060-9"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(23)00315-0"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024026299"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27242"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-199472"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.20025"},{"key":"e_1_3_6_46_1","unstructured":"Peffaul de Latour R Trikha R Mastikova L et al. Interim analysis of the ongoing complete study on the real-world effectiveness of pegcetacoplan in patients with paroxysmal nocturnal hemoglobinuria (PNH): eHA Library 2025 PF 676 [abstract]."},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.20024"},{"key":"e_1_3_6_48_1","unstructured":"Forchade E Loschi M Aroichane M et al. Effectiveness and safety of iptacopan in paroxysmal nocturnal hemoglobinuria patients with persistent anemia after C5 inhibition: the real-world experience of the French early access program. [EHA library 2025 PF671 [abstract]."},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-186453"},{"key":"e_1_3_6_50_1","volume-title":"Zaltenibart, an alternative pathway of complement MASP-3 inhibitor, improved hematologic parameters in PNH patients with persistent anemia on ravulizumab: adjunctive and monotherapy treatment phases.","author":"Griffin M","year":"2025","unstructured":"Griffin M, Kelly RJ, Gavillet M, et al. Zaltenibart, an alternative pathway of complement MASP-3 inhibitor, improved hematologic parameters in PNH patients with persistent anemia on ravulizumab: adjunctive and monotherapy treatment phases. EHA Library; 2025, PF659 [abstract."},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0306407"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(96)00274-6"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(01)00448-8"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-204693"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-178610"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024014652"},{"key":"e_1_3_6_57_1","unstructured":"Hartford C Morag G Jang JH et al. Patient-reported outcomes from a phase 3 randomized trial evaluating the combination of pozelimab and cemdisiran in patients with paroxysmal nocturnal hemoglobinuria. EHA Library; 2025 [PS2292 [abstract]."},{"key":"e_1_3_6_58_1","volume-title":"Health-related quality of life and preference for treatment modalities of patients with paroxysmal nocturnal hemoglobinuria (PNH): results of a real-world study","author":"R\u00f6th A","year":"2025","unstructured":"R\u00f6th A, Balp M, Wiyani A, et al. Health-related quality of life and preference for treatment modalities of patients with paroxysmal nocturnal hemoglobinuria (PNH): results of a real-world study. EHA Library; 2025, PS2291 [abstract]."},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2024.2329030"},{"key":"e_1_3_6_60_1","unstructured":"Barcellini W Fattizzo B Pedone GL et al. Brain MRI findings in untreated patients with paroxysmal nocturnal hemoglobinuria (PNH) [EHA 2025 PF7111 [abstract]."}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2025.2574983","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T07:35:25Z","timestamp":1768376125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2025.2574983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,3]]}},"alternative-id":["10.1080\/14712598.2025.2574983"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2025.2574983","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-07-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}